Fetal Mammalian Heart Generates a Robust Compensatory Response to Cell Loss

Anthony C Sturzu1, Kuppusamy Rajarajan1, Derek Passer1

  • 1From Stanford Cardiovascular Institute (A.C.S., K.R., K.P., A.S., A.F.X., G.L., S.M.W.), Division of Cardiovascular Medicine, Department of Medicine (A.C.S., S.M.W.), Department of Pathology (R.G.), Institute for Stem Cell Biology and Regenerative Medicine (S.M.W.), and Child Health Research Institute (S.M.W.), Stanford University School of Medicine, CA; and Division of Cardiology, Department of Medicine (A.C.S., K.R., D.P., A.R., T.C.T., M.C.E., R.F., K.D.R., M.S.-C., I.J.D.) and Department of Pathology (M.K.S.), Massachusetts General Hospital, Boston.

Circulation
|May 22, 2015
PubMed
Abstract

Insights

Embryonic mouse hearts can regenerate after significant cell loss. Even with up to 60% of cardiac progenitor cells or cardiomyocytes ablated, the heart compensates, ensuring normal fetal development.

Area of Science:

  • Developmental biology
  • Cardiovascular research
  • Regenerative medicine

Background:

  • Heart development relies on precise signaling pathways.
  • Consequences of embryonic cardiac cell loss were previously unclear.
  • Investigated regenerative capacity of embryonic hearts post-cell loss.

Purpose of the Study:

  • To test if embryonic mouse hearts regenerate after extensive cell loss.
  • To define the threshold for cell loss in embryonic mammalian hearts.
  • To understand compensatory mechanisms in embryonic cardiac development.

Main Methods:

  • Conditional cell ablation in murine embryos.
  • Novel blastocyst complementation strategy.
  • Analysis of cardiac progenitor cell and cardiomyocyte ablation.

Main Results:

  • Up to 60% ablation of cardiac progenitor cells at E7.5 was tolerated.
  • 50%-60% embryonic cardiomyocyte ablation at E9.0 was rescued by residual myocytes.
  • Increased cardiomyocyte proliferation contributed to recovery of heart size and cellularity.
  • No obvious adult cardiac functional deficit observed post-ablation.

Conclusions:

  • Embryonic mammalian heart has a defined threshold for cell loss.
  • A robust cardiomyocyte compensatory response sustains fetal development.
  • Identified significant regenerative potential in the developing heart.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.7K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.5K
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
3.9K